66 related articles for article (PubMed ID: 3305243)
21. Pyroglutamic acid improves learning and memory capacities in old rats.
Drago F; Valerio C; D'Agata V; Astuto C; Spadaro F; Continella G; Scapagnini U
Funct Neurol; 1988; 3(2):137-43. PubMed ID: 3402813
[TBL] [Abstract][Full Text] [Related]
22. [The improvement of memory retention and retrieval of a novel vasopressin fragment analog NC-1900].
Sato T; Tanaka K; Ohnishi Y; Teramoto T; Hirate K; Nishikawa T
Nihon Yakurigaku Zasshi; 2002 Nov; 120(1):57P-60P. PubMed ID: 12491780
[TBL] [Abstract][Full Text] [Related]
23. Increase in the septal vasopressin content by prolyl endopeptidase inhibitors in rats.
Miura N; Shibata S; Watanabe S
Neurosci Lett; 1995 Aug; 196(1-2):128-30. PubMed ID: 7501240
[TBL] [Abstract][Full Text] [Related]
24. Effect of nicergoline on learning and memory.
Voronina TA; Nerobkova LN; Garibova TL; Dikova M; Nikolov R; Nikolova M; Markina NV
Methods Find Exp Clin Pharmacol; 1988 Jul; 10(7):431-5. PubMed ID: 3419247
[TBL] [Abstract][Full Text] [Related]
25. Anti-amnesic effect of Chong-Myung-Tang on scopolamine-induced memory impairments in mice.
Lee MR; Yun BS; Park SY; Ly SY; Kim SN; Han BH; Sung CK
J Ethnopharmacol; 2010 Oct; 132(1):70-4. PubMed ID: 20673844
[TBL] [Abstract][Full Text] [Related]
26. Improvement of cationic albumin conjugated pegylated nanoparticles holding NC-1900, a vasopressin fragment analog, in memory deficits induced by scopolamine in mice.
Xie YL; Lu W; Jiang XG
Behav Brain Res; 2006 Oct; 173(1):76-84. PubMed ID: 16828890
[TBL] [Abstract][Full Text] [Related]
27. Central administration of a caspase inhibitor impairs shuttle-box performance in rats.
Stepanichev MY; Kudryashova IV; Yakovlev AA; Onufriev MV; Khaspekov LG; Lyzhin AA; Lazareva NA; Gulyaeva NV
Neuroscience; 2005; 136(2):579-91. PubMed ID: 16198488
[TBL] [Abstract][Full Text] [Related]
28. Time-related memory effects of vasopressin analogues in rats.
Gaffori OJ; De Wied D
Pharmacol Biochem Behav; 1986 Dec; 25(6):1125-9. PubMed ID: 3809214
[TBL] [Abstract][Full Text] [Related]
29. Protective effect of eurystatins A and B, new prolyl endopeptidase inhibitors, on scopolamine-induced amnesia in rats.
Kamei H; Ueki T; Obi Y; Fukagawa Y; Oki T
Jpn J Pharmacol; 1992 Dec; 60(4):377-80. PubMed ID: 1287273
[TBL] [Abstract][Full Text] [Related]
30. Lack of the development of morphine tolerance in experimental amnesia: role of arginine vasopressin.
Sugimachi N; Nakamura T; Takahashi M; Kaneto H
Brain Res; 1993 Apr; 609(1-2):93-7. PubMed ID: 8508324
[TBL] [Abstract][Full Text] [Related]
31. Facilitation of passive avoidance response by newly synthesized cationized arginine vasopressin fragment 4-9 in rats.
Tanabe S; Shishido Y; Furushiro M; Kado K; Hashimoto S; Yokokura T; Ohsawa T
Pharmacol Biochem Behav; 1997; 57(1-2):251-6. PubMed ID: 9164579
[TBL] [Abstract][Full Text] [Related]
32. JTP-4819: a novel prolyl endopeptidase inhibitor with potential as a cognitive enhancer.
Toide K; Iwamoto Y; Fujiwara T; Abe H
J Pharmacol Exp Ther; 1995 Sep; 274(3):1370-8. PubMed ID: 7562510
[TBL] [Abstract][Full Text] [Related]
33. Comparison of inhibitory effects of prolinal-containing peptide derivatives on prolyl endopeptidases from bovine brain and Flavobacterium.
Yoshimoto T; Kawahara K; Matsubara F; Kado K; Tsuru D
J Biochem; 1985 Oct; 98(4):975-9. PubMed ID: 3908451
[TBL] [Abstract][Full Text] [Related]
34. A new model of active avoidance conditioning adequate for pharmacological studies.
Greindl MG; Preat S
Arch Int Pharmacodyn Ther; 1976 Sep; 223(1):168-70. PubMed ID: 999398
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and inhibitory activity of acyl-peptidyl-prolinalderivatives toward post-proline cleaving enzyme as nootropic agents.
Saito M; Hashimoto M; Kawaguchi N; Fukami H; Tanaka T; Higuchi N
J Enzyme Inhib; 1990; 3(3):163-78. PubMed ID: 2079633
[TBL] [Abstract][Full Text] [Related]
36. A novel prolyl endopeptidase inhibitor, JTP-4819, with potential for treating Alzheimer's disease.
Toide K; Shinoda M; Iwamoto Y; Fujiwara T; Okamiya K; Uemura A
Behav Brain Res; 1997 Feb; 83(1-2):147-51. PubMed ID: 9062674
[TBL] [Abstract][Full Text] [Related]
37. Effects of prolyl endopeptidase inhibitors and neuropeptides on delayed neuronal death in rats.
Shishido Y; Furushiro M; Tanabe S; Shibata S; Hashimoto S; Yokokura T
Eur J Pharmacol; 1999 May; 372(2):135-42. PubMed ID: 10395093
[TBL] [Abstract][Full Text] [Related]
38. A major metabolite of arginine vasopressin in the brain is a highly potent neuropeptide.
Burbach JP; Kovács GL; de Wied D; van Nispen JW; Greven HM
Science; 1983 Sep; 221(4617):1310-2. PubMed ID: 6351252
[TBL] [Abstract][Full Text] [Related]
39. Thiazolidine derivatives as potent inhibitors specific for prolyl endopeptidase.
Tsuru D; Yoshimoto T; Koriyama N; Furukawa S
J Biochem; 1988 Oct; 104(4):580-6. PubMed ID: 3071531
[TBL] [Abstract][Full Text] [Related]
40. Slow tight-binding inhibition of prolyl endopeptidase by benzyloxycarbonyl-prolyl-prolinal.
Bakker AV; Jung S; Spencer RW; Vinick FJ; Faraci WS
Biochem J; 1990 Oct; 271(2):559-62. PubMed ID: 2241932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
